Index of reports
> Cases with Pituitary Tumour Recurrent (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Humatrope (Somatropin) where reactions include pituitary tumour recurrent. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Humatrope side effects in 77 year old female
Reported by a consumer/non-health professional from United States on 2012-08-03
Patient: 77 year old female, weighing 69.8 kg (153.7 pounds)
Reactions: Pituitary Tumour Recurrent
Drug(s) suspected as cause:
Humatrope
Possible Humatrope side effects in 35 year old female
Reported by a physician from Japan on 2012-05-24
Patient: 35 year old female
Reactions: Pituitary Tumour Recurrent
Drug(s) suspected as cause:
Humatrope
Possible Humatrope side effects in female
Reported by a physician from United States on 2012-03-30
Patient: female
Reactions: Pituitary Tumour Recurrent
Drug(s) suspected as cause:
Humatrope
Possible Humatrope side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-26
Patient: female
Reactions: Visual Impairment, Pituitary Tumour Recurrent
Drug(s) suspected as cause:
Humatrope
Possible Humatrope side effects in male
Reported by a physician from United States on 2012-03-23
Patient: male
Reactions: Colonic Polyp, Intentional Overdose, Insulin-Like Growth Factor Increased, Pituitary Tumour Recurrent, Self-Medication, Benign Neoplasm of Prostate
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humatrope
Dosage: 0.6 -0.8 mg
Humatrope
Dosage: 0.2 - 0.4 mg, qd
Indication: Hypopituitarism
Possible Humatrope side effects in male
Reported by a consumer/non-health professional from United States on 2011-12-13
Patient: male
Reactions: Colonic Polyp, Intentional Overdose, Pituitary Tumour Recurrent, Insulin-Like Growth Factor Increased, Self-Medication, Benign Neoplasm of Prostate
Drug(s) suspected as cause:
Humatrope
Dosage: 0.2 - 0.4 mg, qd
Indication: Hypopituitarism
Humatrope
Dosage: 0.6 -0.8 mg
|